These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 23578094)

  • 1. L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines.
    Pacchioni SM; Bissa M; Zanotto C; Morghen Cde G; Illiano E; Radaelli A
    J Transl Med; 2013 Apr; 11():95. PubMed ID: 23578094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of mice against the highly pathogenic VV
    Bissa M; Quaglino E; Zanotto C; Illiano E; Rolih V; Pacchioni S; Cavallo F; De Giuli Morghen C; Radaelli A
    Antiviral Res; 2016 Oct; 134():182-191. PubMed ID: 27637905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain.
    Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Illiano E; Granucci F; Zanoni I; Broggi A; Radaelli A
    Virus Res; 2013 Dec; 178(2):374-82. PubMed ID: 24050999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GFP co-expression reduces the A33R gene expression driven by a fowlpox vector in replication permissive and non-permissive cell lines.
    Bissa M; Pacchioni SM; Zanotto C; De Giuli Morghen C; Radaelli A
    J Virol Methods; 2013 Jan; 187(1):172-6. PubMed ID: 23000750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge.
    Berhanu A; Wilson RL; Kirkwood-Watts DL; King DS; Warren TK; Lund SA; Brown LL; Krupkin AK; Vandermay E; Weimers W; Honeychurch KM; Grosenbach DW; Jones KF; Hruby DE
    J Virol; 2008 Apr; 82(7):3517-29. PubMed ID: 18199639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antigen requirements for protection against systemic and intranasal vaccinia virus challenges in mice.
    Kaufman DR; Goudsmit J; Holterman L; Ewald BA; Denholtz M; Devoy C; Giri A; Grandpre LE; Heraud JM; Franchini G; Seaman MS; Havenga MJ; Barouch DH
    J Virol; 2008 Jul; 82(14):6829-37. PubMed ID: 18448519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.
    Golden JW; Josleyn MD; Hooper JW
    Vaccine; 2008 Jun; 26(27-28):3507-15. PubMed ID: 18485547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of recombinant Modified Vaccinia Ankara following a single or multi-dose vaccine regimen in rhesus monkeys.
    Grandpre LE; Duke-Cohan JS; Ewald BA; Devoy C; Barouch DH; Letvin NL; Reinherz EL; Baden LR; Dolin R; Seaman MS
    Vaccine; 2009 Mar; 27(10):1549-56. PubMed ID: 19168105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection.
    Rudraraju R; Ramsay AJ
    Vaccine; 2010 Jul; 28(31):4997-5004. PubMed ID: 20653083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.
    Hooper JW; Ferro AM; Golden JW; Silvera P; Dudek J; Alterson K; Custer M; Rivers B; Morris J; Owens G; Smith JF; Kamrud KI
    Vaccine; 2009 Dec; 28(2):494-511. PubMed ID: 19833247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the deletion of genes encoding proteins of the extracellular virion form of vaccinia virus on vaccine immunogenicity and protective effectiveness in the mouse model.
    Meseda CA; Campbell J; Kumar A; Garcia AD; Merchlinsky M; Weir JP
    PLoS One; 2013; 8(6):e67984. PubMed ID: 23785523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint production of prime/boost pairs of Fowlpox Virus and Modified Vaccinia Ankara recombinants carrying the same transgene.
    Soprana E; Panigada M; Knauf M; Radaelli A; Vigevani L; Palini A; Villa C; Malnati M; Cassina G; Kurth R; Norley S; Siccardi AG
    J Virol Methods; 2011 Jun; 174(1-2):22-8. PubMed ID: 21419167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and use of mammalian-expressed vaccinia virus extracellular membrane proteins for quantification of the humoral immune response to smallpox vaccines.
    García AD; Meseda CA; Mayer AE; Kumar A; Merchlinsky M; Weir JP
    Clin Vaccine Immunol; 2007 Aug; 14(8):1032-44. PubMed ID: 17596428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates.
    Hooper JW; Custer DM; Thompson E
    Virology; 2003 Feb; 306(1):181-95. PubMed ID: 12620810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and longer-term protective immune responses generated by subunit vaccination with smallpox A33, B5, L1 or A27 proteins adjuvanted with aluminum hydroxide and CpG in mice challenged with vaccinia virus.
    Xiao Y; Zeng Y; Schante C; Joshi SB; Buchman GW; Volkin DB; Middaugh CR; Isaacs SN
    Vaccine; 2020 Aug; 38(38):6007-6018. PubMed ID: 32741672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease.
    Golden JW; Zaitseva M; Kapnick S; Fisher RW; Mikolajczyk MG; Ballantyne J; Golding H; Hooper JW
    Virol J; 2011 Sep; 8():441. PubMed ID: 21933385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox.
    Hooper JW; Thompson E; Wilhelmsen C; Zimmerman M; Ichou MA; Steffen SE; Schmaljohn CS; Schmaljohn AL; Jahrling PB
    J Virol; 2004 May; 78(9):4433-43. PubMed ID: 15078924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge.
    Hooper JW; Custer DM; Schmaljohn CS; Schmaljohn AL
    Virology; 2000 Jan; 266(2):329-39. PubMed ID: 10639319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development.
    Lorenzo MM; Nogales A; Chiem K; Blasco R; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0027222. PubMed ID: 35583360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.